These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 34320999)
21. A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting therapy. Sun S; Han R; Sun Y; Chen W; Zhao L; Guan X; Zhang W Colloids Surf B Biointerfaces; 2024 Jun; 238():113909. PubMed ID: 38599076 [TBL] [Abstract][Full Text] [Related]
22. Anticancer and Antibacterial Properties of Curcumin-Loaded Mannosylated Solid Lipid Nanoparticles for the Treatment of Lung Diseases. Chae J; Choi Y; Hong J; Kim N; Kim J; Lee HY; Choi J ACS Appl Bio Mater; 2024 Apr; 7(4):2175-2185. PubMed ID: 38478917 [TBL] [Abstract][Full Text] [Related]
23. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247 [TBL] [Abstract][Full Text] [Related]
24. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer. Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247 [TBL] [Abstract][Full Text] [Related]
25. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018 [TBL] [Abstract][Full Text] [Related]
26. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine. Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129 [TBL] [Abstract][Full Text] [Related]
27. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue. Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349 [TBL] [Abstract][Full Text] [Related]
28. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery. Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310 [TBL] [Abstract][Full Text] [Related]
29. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo. Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689 [TBL] [Abstract][Full Text] [Related]
31. Self-assembled Angelica sinensis polysaccharide nanoparticles with an instinctive liver-targeting ability as a drug carrier for acute alcoholic liver damage protection. Wang K; Xu J; Liu Y; Cui Z; He Z; Zheng Z; Huang X; Zhang Y Int J Pharm; 2020 Mar; 577():118996. PubMed ID: 31904402 [TBL] [Abstract][Full Text] [Related]
32. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors. Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166 [TBL] [Abstract][Full Text] [Related]
33. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Yallapu MM; Ebeling MC; Khan S; Sundram V; Chauhan N; Gupta BK; Puumala SE; Jaggi M; Chauhan SC Mol Cancer Ther; 2013 Aug; 12(8):1471-80. PubMed ID: 23704793 [TBL] [Abstract][Full Text] [Related]
34. Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin. Danafar H; Sharafi A; Askarlou S; Manjili HK Drug Res (Stuttg); 2017 Dec; 67(12):698-704. PubMed ID: 28738425 [TBL] [Abstract][Full Text] [Related]
35. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery. Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623 [TBL] [Abstract][Full Text] [Related]
36. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Ruttala HB; Ko YT Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481 [TBL] [Abstract][Full Text] [Related]
37. Curcumin-loaded PLGA nanoparticles conjugated with anti- P-glycoprotein antibody to overcome multidrug resistance. Punfa W; Suzuki S; Pitchakarn P; Yodkeeree S; Naiki T; Takahashi S; Limtrakul P Asian Pac J Cancer Prev; 2014; 15(21):9249-58. PubMed ID: 25422208 [TBL] [Abstract][Full Text] [Related]
38. GSH triggered intracellular aggregated-cisplatin-loaded iron oxide nanoparticles for overcoming cisplatin resistance in nasopharyngeal carcinoma. Bejjanki NK; Xu H; Xie M J Biomater Appl; 2021 Jul; 36(1):45-54. PubMed ID: 33402041 [TBL] [Abstract][Full Text] [Related]
39. A novel curcuminoid exhibits enhanced antitumor activity in nasopharyngeal carcinoma. Pan Y; Liu G; Xiao J; Su B; Zhou F; Wei Y Int J Oncol; 2016 May; 48(5):2175-83. PubMed ID: 26983360 [TBL] [Abstract][Full Text] [Related]
40. A new curcumin analogue exhibits enhanced antitumor activity in nasopharyngeal carcinoma. Pan Y; Xiao J; Liang G; Wang M; Wang D; Wang S; Yang H Oncol Rep; 2013 Jul; 30(1):239-45. PubMed ID: 23673810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]